A dose-reduction HPV vaccine immunobridging trial of two HPV vaccines among adolescent girls in Tanzania (the DoRIS trial) – Study protocol for a randomised controlled trial

BACKGROUND: Human papillomavirus (HPV) infection is the primary cause of cervical cancer. In 2018, the World Health Organization (WHO) Director General announced his commitment to eliminate cervical cancer, with HPV vaccination as a priority. However, the costs of setting up a multi-dose HPV vaccina...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Contemp Clin Trials
Päätekijät: Baisley, Kathy J., Whitworth, Hilary S., Changalucha, John, Pinto, Ligia, Dillner, Joakim, Kapiga, Saidi, de Sanjosé, Silvia, Mayaud, Philippe, Hayes, Richard J., Lacey, Charles J., Watson-Jones, Deborah
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2021
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7970022/
https://ncbi.nlm.nih.gov/pubmed/33421649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2021.106266
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia